A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females
about
Relapse prevention interventions for smoking cessationNew Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.Reward Responsiveness Varies by Smoking Status in Women with a History of Major Depressive DisorderDo specific NMDA receptor subunits act as gateways for addictive behaviors?
P2860
A double-blind, placebo-controlled trial of the NMDA glycine site antagonist, GW468816, for prevention of relapse to smoking in females
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A double-blind, placebo-contro ...... relapse to smoking in females
@en
A double-blind, placebo-contro ...... relapse to smoking in females.
@nl
type
label
A double-blind, placebo-contro ...... relapse to smoking in females
@en
A double-blind, placebo-contro ...... relapse to smoking in females.
@nl
prefLabel
A double-blind, placebo-contro ...... relapse to smoking in females
@en
A double-blind, placebo-contro ...... relapse to smoking in females.
@nl
P2093
P2860
P50
P1476
A double-blind, placebo-contro ...... relapse to smoking in females
@en
P2093
A Eden Evins
David Mischoulon
Gladys Pachas
Jessica Sousa
Johanna Nino-Gomez
Kate Bentley
Marc J Kaufman
Maurizio Fava
Nancy A Rigotti
Sara Carlini
P2860
P304
P356
10.1097/JCP.0B013E31822BB390
P407
P577
2011-10-01T00:00:00Z